Canadian Department of National Defense Report issue

Government Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00316004
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Canadian Department of National Defense

Active Ingredients

Drugs in Phase 4 Trials (3)

acetaminophen (tylenol) (1 trial)

celecoxib (celebrex) (1 trial)

naproxen (naprosyn) (1 trial)

Drugs in Phase 3 Trials (1)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

naltrexone (revia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5